Lv2
134 积分 2023-12-11 加入
Preclinical characterization and phase 1 results of TQB2102, a first-in-class HER2 biparatopic antibody-drug conjugate, in patients with advanced solid tumors
3个月前
已关闭
Targeting Sialylation Enhances the Therapeutic Efficacy of the Nectin-4–Targeted Antibody–Drug Conjugate Enfortumab Vedotin in Bladder Cancer
5个月前
已关闭
Preclinical models of bladder cancer: BBN and beyond
5个月前
已完结
HER2 and urothelial carcinoma: current understanding and future directions
5个月前
已完结
In Vivo Syngeneic Tumor Models with Acquired Resistance to Anti–PD-1/PD-L1 Therapies
5个月前
已完结
Targeted inhibition of FBXL2 confers susceptibility of HER2-negative breast cancer to trastuzumab deruxtecan
5个月前
已完结
In Vivo Syngeneic Tumor Models with Acquired Resistance to Anti-PD-1/PD-L1 Therapies
6个月前
已完结
From biology to the clinic — exploring liver metastasis in prostate cancer
10个月前
已完结
Biological determinants of PSMA expression, regulation and heterogeneity in prostate cancer
1年前
已完结
Knowledge management mechanisms and common knowledge impacts on the value of knowledge at individual and organizational levels
5个月前
已采纳
Bicalcium Phosphate as an Asset in Regenerative Therapy
5个月前
已采纳
Degree of Standardisation in Ceramic Gingival Systems
5个月前
已采纳
Znhit3 regulates p53/p21 signaling and governs cerebellar granule cell development
5个月前
已采纳
皖公网安备34019202002308
